Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05188729
Title Open-Label Proof of Concept Study of LTX-315 in Basal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verrica Pharmaceuticals Inc.
Indications

basal cell carcinoma

Therapies

LTX-315

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.